The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $191.16

Today's change-1.86 -0.96%
Updated April 17 4:00 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $191.16

Today's change-1.86 -0.96%
Updated April 17 4:00 PM EDT. Delayed by at least 15 minutes.

Illumina Inc crosses below 50-day moving average

Illumina Inc closed lower Friday, dropping (U.S.)$1.86 or 0.96% to (U.S.)$191.16 and crossing below its 50-day moving average. Over the last five days, shares have gained 1.59% and 3.56% year to date. Shares have outperformed the S&P 500 by 29.53% during the last year.

Key company metrics

  • Open(U.S.) $191.11
  • Previous close(U.S.) $193.02
  • High(U.S.) $192.27
  • Low(U.S.) $189.52
  • Bid / Ask-- / --
  • YTD % change+3.56%
  • Volume1,083,169
  • Average volume (10-day)890,464
  • Average volume (1-month)976,604
  • Average volume (3-month)1,066,535
  • 52-week range(U.S.) $128.38 to (U.S.) $213.33
  • Beta0.83
  • Trailing P/E80.47×
  • P/E 1 year forward59.63×
  • Forward PEG2.62×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.38
Updated April 17 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.98%

Based on its net profit margin of 18.98%, Illumina Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 28, 201412/28/2014Sep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014
Revenue512481448421
Total other revenue--------
Total revenue512481448421
Gross profit385334301278
Total cost of revenue127147147142
Total operating expense309361347329
Selling / general / administrative122120115107
Research & development143858277
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-831032
Other operating expenses, total0000
Operating income20311910092
Interest income (expense), net non-operating-11-11-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax1921126084
Income after tax153934760
Income tax, total39191424
Net income153934760
Total adjustments to net income--------
Net income before extra. items153934760
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items153934760
Inc. avail. to common incl. extra. items153934760
Diluted net income153934760
Dilution adjustment------0
Diluted weighted average shares149148149151
Diluted EPS excluding extraordinary itemsvalue per share1.030.630.310.40
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.590.690.330.41